Notícias

Abbott Laboratories (NYSE:ABT) delivered stronger-than-expected second-quarter results and increased its full-year earnings guidance, sending its shares about 2. 5% higher in premarket trading.

Abbott (ABT) delivered earnings and revenue surprises of +2.34% and +0.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

The social media giant is pouring record sums into an artificial intelligence future, forcing investors to decide if they are buying a proven profit machine or funding an unproven science project.

GE Aerospace (NYSE:GE) delivered better-than-expected second-quarter results and upgraded its financial guidance for the full year, supported by continued strength in its commercial services business and improving operational performance. The company reported adjusted earnings of $2.

Halliburton's Q2 results might have reflected stronger completion and drilling activity, tempered by Middle East disruptions and rising costs.

Investing.com -- Abbott (NYSE:ABT) shares are trading higher premarket on Thursday after the company reported second-quarter earnings, topping consensus expectations and raising its full-year earnings guidance.

UnitedHealth Stock Rallies as Profit, Revenue Top Wall Street Expectations

TSMC Stock Drops Even as AI Demand Stays Strong

US banks look like they are trying to move to the upside, but this is a market that has a lot of external influences.

The jet engine maker lifted its adjusted EPS forecast to $7.65–$7.85, up from $7.10–$7.40, after revenue climbed 21% in the quarter

US equity markets were mostly tracking in the red before the opening bell Thursday as traders await

U.S. stocks remain deep in the throes of a major rotation heading into the teeth of the second-quarter earnings season, and the traditional August lull that follows, as investors take money from highflying tech sector and spread that cash across a host of old-economy bets. What’s happening alongside that “great rotation,” however, is also interesting, and likely keeping stocks afloat amid the broader tech declines.

The health insurance giant posted adjusted earnings of $6.38 per share, well above Wall Street estimates, and lifted its full-year adjusted profit guidance to $19.50–$20.00 per share

Semiconductor stocks are dragging Nasdaq futures lower, while UnitedHealth stock jumped 4% after topping earnings expectations

The chipmaker's net income rose 77% year-over-year in the second quarter, beating analyst estimates, as AI chip demand remains strong

Investing.com -- GE Aerospace reported second-quarter results that exceeded analyst expectations and raised its full-year outlook across all metrics, driven by robust commercial services growth.

United Airlines (UAL) raised the low end of its full-year earnings outlook and reported upbeat secon

UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook. Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.

Investing.com -- UnitedHealth Group (NYSE:UNH) reported second quarter results that exceeded analyst expectations across earnings, revenue and guidance, sending shares up 7% premarket as investors responded positively to the healthcare giant's improved outlook.

The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.

AppLovin is set to report Q2 earnings next month, and analysts project its bottom line will improve by double digits.

Investors were set to parse signals on the AI build-out, consumer spending, geopolitical uncertainty, and more in a packed Thursday session.

Wednesday, J.B. Hunt reported earnings per share of $1.91, up 45% year over year, from sales of $3.5 billion, up 19%.

As Mosaic prepares to report its second-quarter earnings next month, Wall Street expects the company to post a double-digit drop in profit.

July 16 (Reuters) - U.S. stock index futures were subdued on Thursday as investors paused after a two-day rally, while chip stocks remained under pressure ahead of fresh economic reports and another

By Tharuniyaa Lakshmi and Johann M Cherian July 16 (Reuters) - European stocks slipped on Thursday as investors assessed a slew of corporate earnings, while escalating tensions in the Middle East

Investing.com -- Taiwan Semiconductor Manufacturing (NYSE:TSM) reported a 77% year-on-year surge in Q2 2026 net profit to a record T$706.6 billion ($21.99 billion) on Thursday, blowing past Wall Street's EPS estimate of $3.80 with a print of $4.31, yet the stock was indicated about 4% lower in premarket trading as investors weighed a sharply expanded capital spending plan against near-term margin pressure.

The world’s largest contract chip maker reported a 77% jump in quarterly profit and revenue equivalent to roughly $40 billion, in line with its guidance. Its gross margin reached a record 67.7%. While the update points to robust demand for AI infrastructure, it seems to have failed to impress investors; TSMC's U.

Optimus is the second-biggest concern, with investors seeking production and deployment updates.

Taiwan Semiconductor Manufacturing (NYSE:TSM) raised its 2026 capital spending plan and full-year revenue outlook as executives said demand for leading-edge chips tied to artificial intelligence remains “extremely robust,” even as some consumer and price-sensitive end markets face pressure. On the